Cargando…
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
Current serology tests for SARS-CoV-2 antibodies mainly take the form of enzyme-linked immunosorbent assays or lateral flow assays, with the former being laborious and the latter being expensive and often lacking sufficient sensitivity and scalability. Here we present the development and validation...
Autores principales: | Elledge, Susanna K., Zhou, Xin X., Byrnes, James R., Martinko, Alexander J., Lui, Irene, Pance, Katarina, Lim, Shion A., Glasgow, Jeff E., Glasgow, Anum A., Turcios, Keirstinne, Iyer, Nikita, Torres, Leonel, Peluso, Michael J., Henrich, Timothy J., Wang, Taia T., Tato, Cristina M., Leung, Kevin K., Greenhouse, Bryan, Wells, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444307/ https://www.ncbi.nlm.nih.gov/pubmed/32839788 http://dx.doi.org/10.1101/2020.08.17.20176925 |
Ejemplares similares
-
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
por: Byrnes, James R., et al.
Publicado: (2020) -
Using Split Luminescent Biosensors for SARS‐CoV‐2 Antibody Detection in Serum, Plasma, and Blood Samples
por: Elledge, Susanna K., et al.
Publicado: (2022) -
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding
por: Byrnes, James R., et al.
Publicado: (2020) -
Reply to Liu et al.: Specific mutations matter in specificity and catalysis in ACE2
por: Glasgow, Jeff, et al.
Publicado: (2021) -
Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells
por: Kirkemo, Lisa L, et al.
Publicado: (2022)